A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...

In addition, he is currently Coordinating Investigator for a multi-site international industry-sponsored study of the frequency and correlates of impulse control disorders in Parkinson's disease.

A major feature of Parkinson’s disease is the loss of dopamine-producing cells in the brain. As dopamine levels decline, it becomes more difficult for the brain to control movement. ADHD is a ...

Parkinson’s disease (PD) affects nearly 2% of adults over 65, making it the second most common neurodegenerative disorder. It ...

NYU economics professor Bill Easterly, a highly respected expert in foreign aid, global poverty and development in Africa, ...

Oct. 10, 2024 — A new technology enables the control ... dopamine in regulating motor function, offering a new therapeutic ... Automatic Speech Recognition Learned to Understand People With ...

Pioneering Cancer TreatmentAnti-tumor Active Pharmaceutical Ingredients (APIs) are vital in today's medical landscape, addressing one of the most pressing health challenges: cancer. These APIs form ...

A photothermal, nanoparticle-based deep brain stimulation system restored motor skills in mice with Parkinson’s-like disease ...

Nerve cells use a brain chemical called dopamine to help control muscle movement ... fibroblasts in adult humans and Parkinson’s disease patients. Such neurons survived transplantation into ...

A by-product of cholesterol plays a "pivotal" role in Parkinson’s disease ... and eventually trigger the death of dopamine neurons." The new study focused on what causes the spread of ...

In addition, he is currently Coordinating Investigator for a multi-site international industry-sponsored study of the frequency and correlates of impulse control disorders in Parkinson's disease.